BioSyent Releases Financial Results for Q3 and YTD 2025
MISSISSAUGA, Ontario, Nov. 20, 2025 (GLOBE NEWSWIRE) — BioSyent Inc. ("BioSyent", TSX Venture: RX) released today its financial results for the three months (Q3) and nine months (YTD) ended September 30, 2025. Key highlights include: (CAD) Q3 2025 % Change vs
(Financial Post, 2025-11-20T22:34:25Z)